Adial Pharmaceuticals Inc (NASDAQ:ADIL)

Adial Pharmaceuticals Inc (NASDAQ:ADIL)


Share Price
$ 7.10
Change
-0.5 (-6.58 %)
Market Cap
$47.70 m
Proactive Investors - Run By Investors For Investors

Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in...

EPIC: ADIL
Market: NASDAQ:ADIL
52-week High/Low: $9.44 / $1.11
Sector: Health Care, Equipment & Services
Market Cap: $47.70M
Website: www.adialpharma.com
col 3
col 4
col 5
col 6

Adial Pharmaceuticals Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use